Monitoring small cell lung cancer (SCLC) by serum neuron specific enolase (S-NSE) analyses using dynamic linear models

Journal of Tumor Marker Oncology

Volumn 11, Issue 4, 1996, Pages 15-21

  Jørgensen, Lone G M ^a   Bøttcher, Susanne G ^b   Christensen, E Susanne ^b   Lundbye Christensen, Søren ^b   Winkel, Per ^c  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b AALBORG UNIVERSITY   (Denmark)

^c NYKØBING FALSTER HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0345089655     PISSN: 08863849     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Carney DN, Marangos PJ, Ihde DC, Bunn PJ, Cohen MH, Minna JD. Serum neuron-specific enolase: A marker for disease extent and response to therapy of small-cell lung cancer. Lancet 1982; i: 583-5.
2. Ledermann JA. Serum neuron specific enolase and other neuroendocrine markers in lung cancer. Eur J Cancer 1994; 30: 576-7.
3. Splinter TAW, Cooper EH, Kho GS, Oosterom R, Peake MD. Neuron specific enolase as a guide to the treatment of small cell lung cancer. Eur J Cancer Clin Oncol 1987; 23: 171-6.
4. Johnson DH, Marangos PJ, Forbes JT, Hainsworth JD, Welch R van, Hande KR, Greco FA. Potential utility of serum neuron specific enolase levels in small cell carcinoma of the lung. Cancer Research 1984; 44: 5409-14.
5. Zandwijk N van, Jassem E, Bonfrer JMG, Tinterin H van. Value of neuron specific enolase in early detection of relapse in small cell lung carcinoma. Eur J Cancer 1990; 26: 373-6.
6. Harris EK. Some theory of reference values. Stratified normal ranges and a method for following and individual's clinical laboratory values. Clin Chem 1975; 21: 1457-64.
7. Winkel P, Bentzon MW, Statland BE, Mouridsen H, Sheike O. Predicting recurrence in patients with breast cancer from cumulative laboratory results: A new technique for the application of time series analysis. Clinical Chemistry 1982; 28: 2057-67.
8. World Health Organization. WHO handbook for Reporting Results of Cancer Treatment. Geneva, 1979.
9. Winkel P, Lundbye-Christensen S, Christensen M. Analysis of serial measurements in clinical practice, pp 105-21. In Magid E (Ed). Some concepts and principles of clinical test evaluation. Nordkem, Helsinki, Finland 1992.
10. West M, Harrison J. Bayesian forecasting and dynamic models. Springer Verlag, 1989.
11. DeGroot MH. Optimal Statistical Decisions. McGraw-Hill Book Company, New York, USA, 1970.
12. Harrison PJ, Stevens CF. Bayesian Forecasting. J Roy Stat 1976; 38: 205-47.
13. Gammelgaard S, Milsgaard MB, Mortensen RS. Monitoring by using dynamic linear models: illustrated by tumour markers for cancer. Master of Science Thesis, IR-95-2005, Institute for Electronic Systems, Aalborg University 1995.
14. Armitage P. Statistical methods in medical research. Blackwell scientific publications, 3th edition, 1994.
15. Smith AFM, West M. Monitoring renal transplants: An application of the multiprocess Kalman Filter. Biometrics 1983; 39: 867-78.
16. Smith AFM, West M, Gordon K, Knapp MS, Trimble IMG. Monitoring kidney transplant patients. The Statistician 1983; 32: 46-54.
17. Lundbye-Christensen S. Monitoring pregnancy. Commun Statist - Stochastic Models 1989; 5: 383-99.
18. Lundbye-Christensen S. A multivariate growth curve model for pregnancy. Biometrics 1991; 47: 637-57.
19. Whittaker J, Frühwirth-Schnatter S. A dynamic changepoint model for detecting the onset of growth in bacteriological infections. Applied Statistics 1994; 43: 625-40.
20. Paus E, Nustad K. Immunoradiometric assay for ag and gg enolase (neuron specific enolase) with use of monoclonal antibodies and magnetizable particles. Clin Chem 1989; 35: 2034-8.